Monographie - Trastuzumab

Последнее обновление :
19/11/2024

Trastuzumab

Товарное название

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Herceptin	Австралия, Австрия, Аргентина, Бельгия, Бразилия, Великобритания, Венгрия, Германия, Голландия, Греция, Дания, Египет, Иран, Ирландия, Исландия, Испания, Италия, Канада, Колумбия, Люксембург, Малайзия, Марокко, Мексика, новая Зеландия, Норвегия, Объединенные Арабские Эмираты, Перу, Польша, Португалия, Румыния, Саудовская Аравия, Соединённые Штаты Америки, Турция, Финляндия, Франция, чили, Швейцария, Швеция, Эквадор, Япония
Herclon	Перу
Hertraz	чили
Herzuma	Бельгия, Великобритания, Германия, Испания, Соединённые Штаты Америки, Франция
Kanjinti	Бельгия, Великобритания, Германия, Испания
Trastuzumab Baxter	новая Зеландия
Trazimera	Великобритания

Библиография : Trastuzumab

	тип	публикация
2296	Лаборатория	Témocilline (Negaban®) - Résumé des caractéristiques du produit Eumedica 2017
2975	плакат	Nalenz H, Schoenhammer K, Dietel E, Heynen S.R, Grauschopf U, Mahler H.C. In-Use stability of herceptin for subcutaneous injection with different administration materials. ESCP 2014 2014
3077	Лаборатория	Trastuzumab (Herceptin®) – Summary of Product Characteristics Roche 2019
3113	Книга	Herceptin Compendium Suisse des m?dicaments 2010
3258	Журнал	Kaiser J, Krämer I. Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags. Int J Pharm Compound 2011 ; 15, 6 : 515-520.
3343	плакат	Vieillard V, da Silva R, Astier A, Paul M. Physicochemical stability of diluted trastuzumab solutions stored 6 months at 4°C. ECOP Congress, Budapest, Hungary 2012
3366	Журнал	Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A. Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration. J Pharm Sci 2012 ; DOI 10.1002 / jps.23403
3386	Журнал	Paul M, Vieillard V, Da Silva Lemos R, Escalup L, Astier A. Long-term physico-chemical stability of diluted trastuzumab. Int J Pharm 2013 ; 448: 101-104.
3647	Лаборатория	Trastuzumab (Herceptin® 600 mg for subcutaneous injection) - Summary of Product Characteristics Roche 2019
3849	Журнал	Pabari R.M, Ryan B, Ahmad W, Ramtoola Z. Physical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutions. Curr Pharm Biotech 2013 ; 14, 2: 220-225.
4163	Журнал	Nalenz H, K?pf E, Dietel E. Prolonged In-Use Stability of Reconstituted Herceptin in Commercial Intravenous Bags. Int J Pharm Compound 2018 22;5:417-423
4191	Журнал	Vieillard V, Astier A, Paul M. Extended stability of a biosimilar of trastuzumab (CT-P6) after reconstitution in vials, dilution in polyolefin bags and storage at varioustemperatures. GaBI Journal 2018
4194	Журнал	Kim S.J, Lee J.W, Kang H.Y, Kim S.Y, Shin Y.K, Kim K.W, Oh J.S, Lim K.J, Kim J.Y. In-Use Physichochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion. Bio Drugs 2018 32;619-625
4271	Журнал	Yun J, Kim J, Chung J, Hwang S-J, Park S-J. Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties Adv Ther 2019
4396	Журнал	Lueras A, Polozova A, Asbury D, Hippenmeyer J, Litowski J, Goss M, Breslin P, Crampton S. Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentrations and stress conditions. GaBI Journal 2020 ; 9, 1:
4477	Журнал	Crampton S, Polozoxa A, Asbury D, Lueras A, Breslin P, Hippenmeyer J, Litkowski J,,Goss M. Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentration and stress conditions. GaBI Journal 2020 ; 9, 1: 5-13.
4493	Журнал	Le Guyader G, Vieillard V, Paul M. Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion. J Oncol Pharm Practice 2020
4649	Журнал	Davies L, Milligan K, Corris M, Clarke I, Dwyer P, Lee S-E, Teraoka J, Crouse-Zeineddini J, Hippenmeyer J. Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices. GaBI Journal 2021 ; 10, 4
4754	Журнал	Weiser S, Burns C, Zartler E Physicochemical stability of PF-05280014 (trastuzumab-qyyp; TrazimeraTM), a trastuzumab biosimilar, under extended in-use conditions. J Oncol Pharm Practice 2023 ;29,3:

Mentions Légales